文献速递免疫规划传染病防控与疫情报告妇幼与学校卫生

古菌脂质佐剂疫苗在幼龄和老年小鼠中诱导强流感免疫应答及母体被动免疫保护

Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
PubMed 文献 · Vaccine · 2019-08-02

本研究在小鼠模型中评估了不同古菌体(archaeosome)配方作为H1N1流感血凝素蛋白佐剂的免疫效果与保护力,并与角鲨烯基水包油纳米乳剂AddaVax™进行比较。结果显示,古菌脂质佐剂可在年轻和老年小鼠中诱导有效的抗HA应答,且可通过母体抗体转移保护幼崽;一种单一硫酸化糖脂SLA的简单混合配方可提供与AddaVax™或传统抗原包封古菌体配方相当或更好的保护。

要点

  • 古菌脂质佐剂在年轻和老年小鼠中均能诱导有效的抗HA IgG和血凝抑制抗体应答。
  • 接种古菌脂质佐剂疫苗的母鼠可通过母体抗体转移保护幼崽免受流感病毒攻击。
  • 单一硫酸化糖脂SLA混合配方提供的保护不劣于或优于AddaVax™及传统包封配方。

核心结论

  • 古菌脂质佐剂可在年轻和老年小鼠中诱导强效流感特异性免疫应答,并可通过母体免疫保护幼崽。
  • 单一硫酸化糖脂SLA的简单混合古菌体配方可提供与AddaVax™或传统抗原包封古菌体配方相当或更好的保护。

研究设计与样本

  • 在小鼠模型中评估不同古菌体配方作为H1N1血凝素蛋白佐剂,并与角鲨烯基水包油纳米乳剂AddaVax™进行比较。
  • 比较年轻成年与老年小鼠的疫苗诱导免疫应答(抗HA IgG和血凝抑制试验滴度)及对A/Puerto Rico/8/1934 H1N1同源攻击的保护。
  • 评估母体抗体转移对幼崽的保护作用。

主要发现

  • 古菌脂质佐剂在年轻和老年小鼠中均可诱导有效的抗HA应答。
  • 接种古菌脂质佐剂的年轻和老年小鼠以及免疫母鼠的幼崽均免受流感病毒攻击。
  • 单一硫酸化糖脂SLA混合配方可提供与AddaVax™或传统抗原包封古菌体配方相当或更好的保护。

临床怎么用

  • 提示古菌脂质佐剂可能改善年轻和老年人群的流感疫苗免疫原性,但尚需人体临床试验验证。
  • 母体免疫策略可能通过被动抗体转移为新生儿提供早期流感保护,需进一步转化研究。

局限性

  • 研究仅在小鼠模型中进行,结果外推到人类需谨慎。
  • 原文摘要未报告具体抗体滴度数值、保护率及统计学差异数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccine induced responses are often weaker in those individuals most susceptible to infection, namely the very young and the elderly, highlighting the need for safe and effective vaccine adjuvants. Herein we evaluated different archaeosome formulations as an adjuvant to the H1N1 influenza hemagglutinin protein and compared immune responses (anti-HA IgG and hemagglutination inhibition assay titers) as well as protection to an influenza A virus (strainA/PuertoRico/8/1934H1N1)homologous challenge to those generated using a squalene-based oil-in-water nano-emulsion, AddaVax™ in a murine model. The impact of age (young adult vs aged) on vaccine induced immune responses as well as the protection in pups due to the transfer of maternal antibodies was measured. Overall, we show that archaeal lipid based adjuvants can induce potent anti-HA responses in young and aged mice that can also be passed from vaccinated mothers to pups. Furthermore, young and aged mice immunized with archaeal lipid adjuvants as well as pups from immunized mothers were protected from challenge with influenza. In addition, we show that a simple admixed archaeosome formulation composed of a single sulfated glycolipid namely sulfated lactosylarchaeol (SLA; 6'-sulfate-β-D-Galp-(1,4)-β-D-Glcp-(1,1)-archaeol) can give equal or better protection compared to AddaVax™ or the traditional antigen-encapsulated archaeosome formulations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Stark FC, Akache B, Ponce A, et al. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization. Vaccine. 2019. PMID: 31383490. doi:10.1016/j.vaccine.2019.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。